BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.76M | 28.07M | 25.42M | 23.94M | 15.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.76M | 28.07M | 25.42M | 23.94M | 15.11M |
| Cost of Revenue | 9.25M | 10.15M | 8.99M | 8.16M | 4.45M |
| Gross Profit | 15.52M | 17.92M | 16.43M | 15.79M | 10.66M |
| SG&A Expenses | 13.46M | 14.60M | 14.13M | 14.10M | 13.15M |
| Depreciation & Amortization | 66.00K | 699.00K | 708.00K | 702.00K | -1.79M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.84M | 28.16M | 26.54M | 25.16M | 14.57M |
| Operating Income | -80.00K | -89.00K | -1.12M | -1.22M | 542.00K |
| Income Before Tax | 1.94M | 703.00K | -15.71M | -434.00K | 469.00K |
| Income Tax Expenses | -173.00K | 82.00K | 126.00K | 14.00K | 24.00K |
| Earnings from Continuing Operations | 2.11M | 621.00K | -15.84M | -448.00K | 445.00K |
| Earnings from Discontinued Operations | 8.96M | -- | -- | -- | 12.01M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.07M | 621.00K | -15.84M | -448.00K | 12.46M |
| EBIT | -80.00K | -89.00K | -1.12M | -1.22M | 542.00K |
| EBITDA | 506.00K | 1.25M | 260.00K | 166.00K | 2.25M |
| EPS Basic | 0.23 | 0.01 | -0.33 | -0.01 | 0.27 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.00 | -0.01 | 0.01 |
| EPS Diluted | 0.22 | 0.01 | -0.33 | -0.01 | 0.26 |
| Normalized Diluted EPS | 0.02 | 0.01 | 0.00 | -0.01 | 0.01 |
| Average Basic Shares Outstanding | 48.14M | 47.93M | 47.80M | 47.13M | 46.65M |
| Average Diluted Shares Outstanding | 49.01M | 48.72M | 47.80M | 47.13M | 48.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |